Samantha Schilling1, Margaret Samuels-Kalow2, Jeffrey S Gerber3, Philip V Scribano4, Benjamin French5, Joanne N Wood6. 1. Divisions of General Pediatrics and Leonard Davis Institute of Health Economics, samantha_schilling@med.unc.edu. 2. Leonard Davis Institute of Health Economics, Emergency Medicine, and. 3. Departments of Pediatrics, and Biostatistics and Epidemiology, and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 4. Divisions of General Pediatrics and Departments of Pediatrics, and. 5. Leonard Davis Institute of Health Economics, Biostatistics and Epidemiology, and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. 6. Divisions of General Pediatrics and Leonard Davis Institute of Health Economics, Departments of Pediatrics, and PolicyLab, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and.
Abstract
OBJECTIVE: To examine rates of recommended of testing and prophylaxis for chlamydia, gonorrhea, and pregnancy in adolescents diagnosed with sexual assault across pediatric emergency departments (EDs) and to determine whether specialized sexual assault pathways and teams are associated with performance of recommended testing and prophylaxis. METHODS: In this retrospective study of 12- to 18-year-old adolescents diagnosed with sexual assault at 38 EDs in the Pediatric Hospital Information System database from 2004 to 2013, information regarding routine practice for sexual assault evaluations and presence and year of initiation of specialized ED sexual assault pathways and teams was collected via survey. We examined across-hospital variation and identified patient- and hospital-level factors associated with testing and prophylaxis using logistic regression models, accounting for clustering by hospital. RESULTS: Among 12,687 included cases, 93% were female, 79% were <16 years old, 34% were non-Hispanic white, 38% were non-Hispanic black, 21% were Hispanic, and 52% had public insurance. Overall, 44% of adolescents received recommended testing (chlamydia, gonorrhea, pregnancy) and 35% received recommended prophylaxis (chlamydia, gonorrhea, emergency contraception). Across EDs, unadjusted rates of testing ranged from 6% to 89%, and prophylaxis ranged from 0% to 57%. Presence of a specialized sexual assault pathway was associated with increased rates of prophylaxis even after adjusting for case-mix and temporal trends (odds ratio 1.46, 95% confidence interval 1.15 to 1.86). CONCLUSIONS: Evaluation and treatment of adolescent sexual assault victims varied widely across pediatric EDs. Adolescents cared for in EDs with specialized sexual assault pathways were more likely to receive recommended prophylaxis.
OBJECTIVE: To examine rates of recommended of testing and prophylaxis for chlamydia, gonorrhea, and pregnancy in adolescents diagnosed with sexual assault across pediatric emergency departments (EDs) and to determine whether specialized sexual assault pathways and teams are associated with performance of recommended testing and prophylaxis. METHODS: In this retrospective study of 12- to 18-year-old adolescents diagnosed with sexual assault at 38 EDs in the Pediatric Hospital Information System database from 2004 to 2013, information regarding routine practice for sexual assault evaluations and presence and year of initiation of specialized ED sexual assault pathways and teams was collected via survey. We examined across-hospital variation and identified patient- and hospital-level factors associated with testing and prophylaxis using logistic regression models, accounting for clustering by hospital. RESULTS: Among 12,687 included cases, 93% were female, 79% were <16 years old, 34% were non-Hispanic white, 38% were non-Hispanic black, 21% were Hispanic, and 52% had public insurance. Overall, 44% of adolescents received recommended testing (chlamydia, gonorrhea, pregnancy) and 35% received recommended prophylaxis (chlamydia, gonorrhea, emergency contraception). Across EDs, unadjusted rates of testing ranged from 6% to 89%, and prophylaxis ranged from 0% to 57%. Presence of a specialized sexual assault pathway was associated with increased rates of prophylaxis even after adjusting for case-mix and temporal trends (odds ratio 1.46, 95% confidence interval 1.15 to 1.86). CONCLUSIONS: Evaluation and treatment of adolescent sexual assault victims varied widely across pediatric EDs. Adolescents cared for in EDs with specialized sexual assault pathways were more likely to receive recommended prophylaxis.
Authors: Susan Y Euling; Marcia E Herman-Giddens; Peter A Lee; Sherry G Selevan; Anders Juul; Thorkild I A Sørensen; Leo Dunkel; John H Himes; Grete Teilmann; Shanna H Swan Journal: Pediatrics Date: 2008-02 Impact factor: 7.124
Authors: Arti Barnes; Katelyn K Jetelina; Andrea C Betts; Theresa Mendoza; Pranavi Sreeramoju; Jasmin A Tiro Journal: Sex Transm Dis Date: 2019-07 Impact factor: 2.830
Authors: Abbey R Masonbrink; Troy Richardson; Russell J McCulloh; Matt Hall; Jessica L Bettenhausen; Jacqueline M Walker; Matthew B Johnson; Mary Ann Queen; Jessica L Markham; Monika K Goyal Journal: J Adolesc Health Date: 2018-07-31 Impact factor: 5.012
Authors: Ruhee Shah; Alessandra Della Porta; Sherman Leung; Margaret Samuels-Kalow; Elizabeth M Schoenfeld; Lynne D Richardson; Michelle P Lin Journal: West J Emerg Med Date: 2021-10-27